Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Chronic fatigue syndrome (CFS) is a devastating and complex disorder. People with CFS
experience overwhelming fatigue and a host of other symptoms that are not improved by bed
rest. Interestingly, many of the symptoms experienced by people with CFS are identical to
symptoms caused by long-term low-level exposure to mercury, which is called
micromercurialism.
This study will examine if the mercury binding substance IodoCarb(r) can improve the health
of patients with CFS.